Atopic dermatitis and risk for headache disorders and migraines: a population-based cohort study in children and adults from the UK.

Competing Interests: Conflicts of interest J.W. has received research and fellowship funding from Pfizer, Inc. (paid to Johns Hopkins University) and served as a consultant to Janssen and Sun Pharmaceuticals, receiving honoraria. M.N.S. has received fellowship funding from Pfizer, Inc. (paid to the University of Pennsylvania). K.A. has received research funding from Pfizer, Inc. and L’Oréal (paid to University of California San Francisco), and receives consulting fees for serving on the academic steering committee for TARGET RWE. Z.C.C.F. has received research grants from Lilly, LEO Pharma, Regeneron, Sanofi, Tioga and Vanda for work related to atopic dermatitis and from Menlo Therapeutics and Galderma for work related to prurigo nodularis. She has also served as consultant for the Asthma and Allergy Foundation of America, National Eczema Association, AbbVie, Incyte Corporation and Pfizer, and received honoraria for continuing medical education work in atopic dermatitis sponsored by education grants from Regeneron/Sanofi and Pfizer and from Beirsdorf for work related to skin cancer and sun protection. J.M.G. has served as a consultant for Abcentra, AbbVie, BMS, Boehringer Ingelheim, GSK, Lilly (DMC), Janssen Biologics, Novartis Corp, UCB (DSMB), Neuroderm (DSMB), Trevi, and Mindera Dx, receiving honoraria. J.M.G. receives research grants (to the Trustees of the University of Pennsylvania) from Boehringer Ingelheim and Pfizer Inc. and has received payment for continuing medical education work related to psoriasis that was supported indirectly by pharmaceutical sponsors. J.M.G. is a copatent holder of resiquimod for the treatment of cutaneous T-cell lymphoma, serves as a Deputy Editor for the Journal of Investigative Dermatology, receiving honoraria from the Society for Investigative Dermatology, is Chief Medical Editor for Healio Psoriatic Disease (receiving honoraria), and is a member of the Board of Directors for the International Psoriasis Council, receiving no honoraria.